Urachal urothelial carcinoma diagnosed at a radical prostatectomy operation: a case report.

Nalan Nese, Gonca Kesici, Murat Lekili, Aydin Isisag
{"title":"Urachal urothelial carcinoma diagnosed at a radical prostatectomy operation: a case report.","authors":"Nalan Nese,&nbsp;Gonca Kesici,&nbsp;Murat Lekili,&nbsp;Aydin Isisag","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Urachal carcinomas are rare tumors, and the majority of them are adenocarcinomas. Up to now, only 21 urachal urothelial carcinomas (UCas) have been reported. Here, we describe a case of high grade UCa arising from the urachal remnants.</p><p><strong>Case: </strong>A 66-year-old man presented with voiding difficulties. Prostate specific antigen (PSA) was 5.46 ng/mL. Prostatic adenocarcinoma (PCa) (Gleason score 6) was diagnosed by needle biopsies. After the diagnosis of high grade, muscle invasive UCa with intact mucosa on frozen examination of the dome of bladder wall during the radical prostatectomy operation (RPO), partial cystectomy was performed. Microscopically, among the tumoral islands, cystic structures lined by cells with a benign appearance, which are considered urachal remnants, were noted. Cytokeratin 7 and high-molecular-weight cytokeratin were strongly positive, PSA and carcinoembryonic antigen were negative. Radiotherapy was given for both UCa and PCa. Six months after the diagnosis, an undifferentiated tumor was detected in a bladder transurethral resection specimen; thus, chemotherapy was given. After 1 course of chemotherapy, the patient was doing well.</p><p><strong>Conclusion: </strong>The origin of urachal carcinomas is usually obscured as it is a highly invasive carcinoma. The patient presented here was diagnosed incidentally during RPO. Although the stage was advanced, the tumor was detected before urachal remnants were destroyed. The treatment choice for urachal carcinomas is cystectomy. Adjuvant chemotherapy and radiotherapy are controversial.</p>","PeriodicalId":76995,"journal":{"name":"Analytical and quantitative cytology and histology","volume":"32 3","pages":"174-7"},"PeriodicalIF":0.0000,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Analytical and quantitative cytology and histology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Urachal carcinomas are rare tumors, and the majority of them are adenocarcinomas. Up to now, only 21 urachal urothelial carcinomas (UCas) have been reported. Here, we describe a case of high grade UCa arising from the urachal remnants.

Case: A 66-year-old man presented with voiding difficulties. Prostate specific antigen (PSA) was 5.46 ng/mL. Prostatic adenocarcinoma (PCa) (Gleason score 6) was diagnosed by needle biopsies. After the diagnosis of high grade, muscle invasive UCa with intact mucosa on frozen examination of the dome of bladder wall during the radical prostatectomy operation (RPO), partial cystectomy was performed. Microscopically, among the tumoral islands, cystic structures lined by cells with a benign appearance, which are considered urachal remnants, were noted. Cytokeratin 7 and high-molecular-weight cytokeratin were strongly positive, PSA and carcinoembryonic antigen were negative. Radiotherapy was given for both UCa and PCa. Six months after the diagnosis, an undifferentiated tumor was detected in a bladder transurethral resection specimen; thus, chemotherapy was given. After 1 course of chemotherapy, the patient was doing well.

Conclusion: The origin of urachal carcinomas is usually obscured as it is a highly invasive carcinoma. The patient presented here was diagnosed incidentally during RPO. Although the stage was advanced, the tumor was detected before urachal remnants were destroyed. The treatment choice for urachal carcinomas is cystectomy. Adjuvant chemotherapy and radiotherapy are controversial.

在根治性前列腺切除术中诊断的尿管尿路上皮癌1例报告。
背景:尿管癌是一种罕见的肿瘤,以腺癌为主。迄今为止,仅有21例尿路上皮癌被报道。在这里,我们描述了一例由乌拉恰尔残余引起的高级别UCa。病例:66岁男性排尿困难。前列腺特异性抗原(PSA)为5.46 ng/mL。前列腺腺癌(PCa) (Gleason评分6)通过针活检诊断。在根治性前列腺切除术(RPO)中,膀胱壁穹顶冰冻检查诊断为高级别、肌肉侵袭性UCa,粘膜完整,行部分膀胱切除术。显微镜下,在肿瘤岛中,可见由良性细胞排列的囊性结构,被认为是尿路残余。细胞角蛋白7和高分子量细胞角蛋白呈强阳性,PSA和癌胚抗原呈阴性。UCa和PCa均行放射治疗。诊断后6个月,膀胱经尿道切除标本中发现未分化肿瘤;因此,给予化疗。经过1个疗程的化疗,患者恢复良好。结论:由于尿管癌是一种高度侵袭性的癌,其起源往往不明确。这里的病人是在RPO期间偶然诊断出来的。虽然已进入晚期,但肿瘤是在urachal残余被破坏之前被发现的。尿管癌的治疗选择是膀胱切除术。辅助化疗和放疗是有争议的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信